BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16253214)

  • 1. Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling.
    Manso AM; Elsherif L; Kang SM; Ross RS
    Cardiovasc Res; 2006 Feb; 69(3):574-84. PubMed ID: 16253214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix modulation and heart failure: new concepts question old beliefs.
    Deschamps AM; Spinale FG
    Curr Opin Cardiol; 2005 May; 20(3):211-6. PubMed ID: 15861009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac remodeling and failure From molecules to man (Part II).
    Fedak PW; Verma S; Weisel RD; Li RK
    Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of changes of matrix metalloproteinase in cardiovascular diseases].
    Gasanov AG; Bershova TV
    Biomed Khim; 2009; 55(2):155-68. PubMed ID: 19507339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
    Lindsey ML; Iyer RP; Jung M; DeLeon-Pennell KY; Ma Y
    J Mol Cell Cardiol; 2016 Feb; 91():134-40. PubMed ID: 26721597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-associated matrix proteolysis and heart failure.
    Spinale FG; Janicki JS; Zile MR
    Circ Res; 2013 Jan; 112(1):195-208. PubMed ID: 23287455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
    Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
    Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.
    Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA; Murray DB; Chancey AL
    Cardiovasc Res; 2006 Feb; 69(3):657-65. PubMed ID: 16376324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial extracellular matrix remodeling in ischemic heart failure.
    Gallagher GL; Jackson CJ; Hunyor SN
    Front Biosci; 2007 Jan; 12():1410-9. PubMed ID: 17127391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial proteases and matrix remodeling in inflammatory heart disease.
    Rutschow S; Li J; Schultheiss HP; Pauschinger M
    Cardiovasc Res; 2006 Feb; 69(3):646-56. PubMed ID: 16417902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways that influence extracellular remodeling.
    Lee RT; Lammerding J
    J Card Fail; 2002 Dec; 8(6 Suppl):S339-43. PubMed ID: 12555142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
    Schram K; Sweeney G
    Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloproteinase in myocardial adaptation and maladaptation.
    Tyagi SC; Hoit BD
    J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):241-6. PubMed ID: 12490970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruptions and detours in the myocardial matrix highway and heart failure.
    Deschamps AM; Spinale FG
    Curr Heart Fail Rep; 2005 Mar; 2(1):10-7. PubMed ID: 16036046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.
    Vanhoutte D; Heymans S
    J Mol Cell Cardiol; 2010 Mar; 48(3):445-53. PubMed ID: 19799912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial structure and matrix metalloproteinases.
    Aggeli C; Pietri P; Felekos I; Rautopoulos L; Toutouzas K; Tsiamis E; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1113-31. PubMed ID: 22519443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling myocardial matrix remodeling: implications for heart failure.
    Rao VU; Spinale FG
    Cardiol Rev; 1999; 7(3):136-43. PubMed ID: 10423664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.